Literature DB >> 17622243

Transduction of human embryonic stem cells by foamy virus vectors.

Helen Gharwan1, Roli K Hirata, Peirong Wang, Robert E Richard, Linlin Wang, Erik Olson, James Allen, Carol B Ware, David W Russell.   

Abstract

Human embryonic stem cells (hESCs) are important tools for the study of stem cell biology and may ultimately be used in cellular therapies and regenerative medicine. For hESCs to achieve their potential, stable genetic modification of the hESC genome will be required. Here we have studied the transduction of hESCs by vectors based on foamy virus (FV), an integrating retrovirus with no known pathogenicity. We find that hESCs and also ESCs derived from rhesus monkeys can be efficiently transduced by FV vectors at frequencies of 14-48%. Integration of FV vector DNA was demonstrated by Southern blot analysis, and stable expression was observed from a single integrated provirus in several clones. Transduced hESCs expressed markers characteristic of undifferentiated cells, differentiated and expressed markers from all three germ layers after serum exposure, and formed teratomas with persistent transgene expression in differentiated cells. Thus, FV vectors are promising tools for the genetic modification of hESCs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17622243     DOI: 10.1038/sj.mt.6300244

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  10 in total

1.  Advances in foamy virus vector technology and disease correction could speed the path to clinical application.

Authors:  Els Verhoeyen
Journal:  Mol Ther       Date:  2012-06       Impact factor: 11.454

2.  Globin phenotype of erythroid cells derived from human induced pluripotent stem cells.

Authors:  Kai-Hsin Chang; Andy Huang; Roli K Hirata; Pei-Rong Wang; David W Russell; Thalia Papayannopoulou
Journal:  Blood       Date:  2010-03-25       Impact factor: 22.113

3.  Nonintegrating foamy virus vectors.

Authors:  David R Deyle; Yi Li; Erik M Olson; David W Russell
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

4.  Normal collagen and bone production by gene-targeted human osteogenesis imperfecta iPSCs.

Authors:  David R Deyle; Iram F Khan; Gaoying Ren; Pei-Rong Wang; Jordan Kho; Ulrike Schwarze; David W Russell
Journal:  Mol Ther       Date:  2011-10-25       Impact factor: 11.454

5.  HLA engineering of human pluripotent stem cells.

Authors:  Laura Riolobos; Roli K Hirata; Cameron J Turtle; Pei-Rong Wang; German G Gornalusse; Maja Zavajlevski; Stanley R Riddell; David W Russell
Journal:  Mol Ther       Date:  2013-04-30       Impact factor: 11.454

6.  Engineering of human pluripotent stem cells by AAV-mediated gene targeting.

Authors:  Iram F Khan; Roli K Hirata; Pei-Rong Wang; Yi Li; Jordan Kho; Angel Nelson; Yunwen Huo; Maja Zavaljevski; Carol Ware; David W Russell
Journal:  Mol Ther       Date:  2010-04-20       Impact factor: 11.454

Review 7.  Foamy virus vectors for gene transfer.

Authors:  Grant D Trobridge
Journal:  Expert Opin Biol Ther       Date:  2009-11       Impact factor: 4.388

Review 8.  Foamy virus biology and its application for vector development.

Authors:  Dirk Lindemann; Axel Rethwilm
Journal:  Viruses       Date:  2011-05-11       Impact factor: 5.048

9.  Generation, purification and transplantation of photoreceptors derived from human induced pluripotent stem cells.

Authors:  Deepak A Lamba; Andrew McUsic; Roli K Hirata; Pei-Rong Wang; David Russell; Thomas A Reh
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

Review 10.  Strategies for Targeting Retroviral Integration for Safer Gene Therapy: Advances and Challenges.

Authors:  Kristine E Yoder; Anthony J Rabe; Richard Fishel; Ross C Larue
Journal:  Front Mol Biosci       Date:  2021-05-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.